Icahn School of Medicine at Mount Sinai Licenses Next-Generation Diagnostic Test Epigenetic /AI Platform to GNOMX Corp.

Press/Media

Period	20 Sep 2023

Media coverage

Title	Icahn School of Medicine at Mount Sinai Licenses Next-Generation Diagnostic Test Epigenetic /AI Platform to GNOMX Corp.
Media name/outlet	Targeted News Service
Country/Territory	United States
Date	20/09/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=696W-FB71-DYG2-R0RR-00000-00
Persons	Stuart Sealfon